ABSI
Price
$2.23
Change
-$0.25 (-10.08%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
315.79M
46 days until earnings call
SONN
Price
$1.27
Change
-$0.04 (-3.05%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
3.89M
Ad is loading...

ABSI vs SONN

Header iconABSI vs SONN Comparison
Open Charts ABSI vs SONNBanner chart's image
Absci
Price$2.23
Change-$0.25 (-10.08%)
Volume$42.62K
Capitalization315.79M
Sonnet BioTherapeutics Holdings
Price$1.27
Change-$0.04 (-3.05%)
Volume$100
Capitalization3.89M
ABSI vs SONN Comparison Chart
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. SONN commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and SONN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ABSI: $2.23 vs. SONN: $1.27)
Brand notoriety: ABSI and SONN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 61% vs. SONN: 32%
Market capitalization -- ABSI: $315.79M vs. SONN: $3.89M
ABSI [@Biotechnology] is valued at $315.79M. SONN’s [@Biotechnology] market capitalization is $3.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileSONN’s FA Score has 1 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • SONN’s FA Score: 1 green, 4 red.
According to our system of comparison, both ABSI and SONN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 5 TA indicator(s) are bullish while SONN’s TA Score has 4 bullish TA indicator(s).

  • ABSI’s TA Score: 5 bullish, 6 bearish.
  • SONN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SONN is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а -20.46% price change this week, while SONN (@Biotechnology) price change was -3.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

ABSI is expected to report earnings on May 20, 2025.

SONN is expected to report earnings on Nov 29, 2023.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABSI($316M) has a higher market cap than SONN($3.89M). ABSI YTD gains are higher at: -5.344 vs. SONN (-13.014). SONN has higher annual earnings (EBITDA): -13.33M vs. ABSI (-83.27M). ABSI has more cash in the bank: 127M vs. SONN (4.86M). SONN has less debt than ABSI: SONN (111K) vs ABSI (12M). ABSI has higher revenues than SONN: ABSI (4.21M) vs SONN (1M).
ABSISONNABSI / SONN
Capitalization316M3.89M8,117%
EBITDA-83.27M-13.33M624%
Gain YTD-5.344-13.01441%
P/E RatioN/A0.29-
Revenue4.21M1M421%
Total Cash127M4.86M2,612%
Total Debt12M111K10,811%
FUNDAMENTALS RATINGS
SONN: Fundamental Ratings
SONN
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABSISONN
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
89%
Bullish Trend 15 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WICVX9.190.14
+1.55%
Wasatch Small Cap Value Institutional
MRGHX48.660.39
+0.81%
MFS Core Equity R3
RLISX23.640.12
+0.53%
Russell Inv Equity Income S
GEQIX14.860.02
+0.13%
Glenmede Equity Income
RSPFX26.87N/A
N/A
Victory RS Partners A

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with RXRX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
+3.33%
RXRX - ABSI
56%
Loosely correlated
+3.83%
ABCL - ABSI
54%
Loosely correlated
+6.22%
BEAM - ABSI
54%
Loosely correlated
+4.79%
CRSP - ABSI
54%
Loosely correlated
+3.17%
NTLA - ABSI
48%
Loosely correlated
+9.69%
More

SONN and

Correlation & Price change

A.I.dvisor tells us that SONN and VANI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SONN and VANI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONN
1D Price
Change %
SONN100%
-3.05%
VANI - SONN
28%
Poorly correlated
-1.98%
DWTX - SONN
27%
Poorly correlated
+5.68%
ABSI - SONN
26%
Poorly correlated
-9.88%
IGMS - SONN
26%
Poorly correlated
-5.69%
PRME - SONN
25%
Poorly correlated
-10.06%
More